Back
Design Therapeutics Stock Predictions
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
DSGN
Design Therapeutics
Last Price:
5.88
Seasonality Move:
-19.8%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Design Therapeutics Stock Forecast
- Over the next 52 weeks, Design Therapeutics has on average historically risen by 20.9% based on the past 3 years of stock performance.
- Design Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Design Therapeutics Stock Undervalued?
The current Design Therapeutics [DSGN] share price is $5.88. The Score for DSGN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal. - DSGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Design Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Design Therapeutics has on average historically risen by 20.9% based on the past 3 years of stock performance.
Design Therapeutics Stock Rating
Sell
47
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics overpriced?
- Design Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Design Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
designtx.com
52-Week Data
52-Week High:
6.91
52-Week Low:
1.96
Prediction Charts
Market Cap:
332.93M
Price in USD:
5.88
Volume:
405.16K
Beta:
1.84
Technical Analysis
SMA50:
4.82
SMA100:
4.35
SMA200:
3.62
52-Wk Change:
139.02%
Stock Predictions
-
Is Design Therapeutics stock public?
Yes, Design Therapeutics is a publicly traded company. -
What is the Design Therapeutics stock quote today?
The Design Therapeutics stock price is 5.88 USD today. -
How to buy Design Therapeutics stock online?
You can buy Design Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-3 | 4.77 | 4.73 | 4.86 | 4.61 |
| Sep-4 | 4.67 | 4.81 | 4.87 | 4.52 |
| Sep-5 | 4.85 | 4.71 | 4.85 | 4.60 |
| Sep-6 | 4.72 | 4.68 | 4.79 | 4.50 |
| Sep-9 | 4.58 | 4.88 | 4.97 | 4.58 |
| Sep-10 | 5.10 | 5.64 | 6.91 | 4.98 |
| Sep-11 | 5.65 | 5.22 | 5.79 | 5.05 |
| Sep-12 | 5.36 | 5.84 | 6.01 | 5.35 |
| Sep-13 | 5.85 | 5.54 | 5.97 | 5.20 |
| Sep-16 | 5.57 | 5.55 | 5.86 | 5.44 |
| Sep-17 | 5.62 | 5.77 | 5.96 | 5.55 |
| Sep-18 | 5.75 | 5.64 | 5.87 | 5.56 |
| Sep-19 | 5.79 | 5.86 | 5.95 | 5.71 |
| Sep-20 | 5.82 | 5.88 | 6.13 | 5.77 |
Design Therapeutics Earnings
Design Therapeutics Earnings Report: Per Share Design Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Design Therapeutics Forecast Revenue Growth
Design Therapeutics Stock Analysis: Historical quarterly revenues per share for Design Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.